ICCC
ImmuCell Corporation
NASDAQ · Healthcare · Biotechnology · US
$9.90
−1.00%Aug 14, 2026, 14:05 UTC
ImmuCell announced plans to invest about $8 million to more than triple manufacturing capacity by the end of 2027.
Source:
NASDAQ · Healthcare · Biotechnology · US
Aug 14, 2026, 14:05 UTC